1. Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study.
- Author
-
Bronowicka-Szydełko A, Lewandowski Ł, Lubieniecki P, Adamiec-Mroczek J, Doroszko A, Trocha M, Kujawa K, Matera-Witkiewicz A, Rabczyński M, Kuźnik E, Madziarski M, Sokołowski J, Jankowska EA, and Madziarska K
- Subjects
- Humans, Male, Middle Aged, Female, Aged, SARS-CoV-2 isolation & purification, Glucose Metabolism Disorders therapy, Glucose Metabolism Disorders blood, Hospitalization, Oxygen metabolism, COVID-19 therapy, COVID-19 blood, Oxygen Saturation, Oxygen Inhalation Therapy methods, Diabetes Mellitus, Type 2 therapy, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 metabolism
- Abstract
The COVID-19 pandemic has revealed that viruses can have multiple receptor properties, penetrating various tissues and causing mutations in various genes, thus promoting a range of metabolic disorders. The purpose of this study was to investigate the connection between three factors: diabetic status, pre-hospitalization oxygen therapy, and saturation levels, to the values of morphological, inflammatory, and biochemical parameters in the blood serum of COVID-19 patients. The study group consisted of 2139 patients, 1076 women (50.30%) and 1063 men (49.70%), with an average age of 63.73 ± 15.69 years. The population was divided into three groups based on a three-stage scale, taking into account patients with either type 2 diabetes/prediabetes (473 patients), those who received oxygen therapy before hospitalization, and those with a saturation value of below 95% (cut-off value). Among patients who did not receive pre-hospitalization oxygen therapy, those with diabetes and a SpO2 level < 95% had significantly higher levels of D-dimers, procalcitonin, albumin, lymphocytes, RDW-SD ≥ 47, potassium, creatinine, and troponin T when compared to diabetic patients with a SpO2 level ≥ 95%. Similarly, in the same group of patients without pre-hospitalization oxygen therapy, those without diabetes but with a SpO2 level < 95% showed significantly increased levels of IL-6, CRP, albumin, lymphocytes, RDW-SD ≥ 47, glucose, potassium, sodium, creatinine, and ALT, compared to patients without diabetes and with a SpO2 level ≥ 95%. The findings suggest that lower saturation levels may result in increased potassium and glucose levels in patients who did not receive any oxygen therapy before hospitalization due to COVID-19. It is hypothesized that this may be caused by damage to pancreatic β-cells by SARS-CoV-2, and disturbances in the potassium channel, leading to cell membrane depolarization and insulin secretion., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF